These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 14364499)

  • 1. Studies with four distinct lines of the Ehrlich ascites tumor for the evaluation of twenty-seven potential inhibitors.
    CREECH HJ; HAUSCHKA TS; HANKWITZ RJ; LITTLETON BJ; ANDRE J
    Cancer Res; 1955; Suppl. 3():47-51. PubMed ID: 14364499
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on growth and regression of Ehrlich mouse ascites tumor heterotransplants.
    HORAVA A; VON HAAM E
    Cancer Res; 1958 Aug; 18(7):753-9. PubMed ID: 13573338
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of furfuralacetone and related compounds on Ehrlich ascites tumor.
    FURST A; CUTTING WC; DREISBACH RH
    Stanford Med Bull; 1954 Aug; 12(3):190-4. PubMed ID: 13187123
    [No Abstract]   [Full Text] [Related]  

  • 4. Influenceability of subcutaneous transplantation of Ehrlich mouse ascites tumor in rats.
    HACKENSELLNER HA; HERMANEK P
    Oncologia; 1958; 11(3-4):199-217. PubMed ID: 13600767
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of X-irradiation on the growth of the Ehrlich ascites tumor.
    REVESZ L
    J Natl Cancer Inst; 1955 Jun; 15(6):1691-701. PubMed ID: 14381893
    [No Abstract]   [Full Text] [Related]  

  • 6. Tests of compounds against the Ehrlich ascites tumor.
    FURST A; CUTTING WC
    Cancer Res; 1955; Suppl. 2():73-80. PubMed ID: 14379182
    [No Abstract]   [Full Text] [Related]  

  • 7. Retardation of growth of Ehrlich ascites tumor by formamides and related compounds.
    FURST A; CUTTING WC; GROSS H
    Cancer Res; 1955 Jun; 15(5):294-9. PubMed ID: 14379167
    [No Abstract]   [Full Text] [Related]  

  • 8. [Characteristics of taking and invasiveness of the Ehrlich "ascites tumor" inoculatated into various organs of the mouse].
    GIOVANELLA B
    Arch Ital Anat Istol Patol; 1959 Oct; 33():392-412. PubMed ID: 13705594
    [No Abstract]   [Full Text] [Related]  

  • 9. Tests of compounds against the Ehrlich mouse ascites tumor.
    LETTRE H
    Cancer Res; 1955; Suppl. 2():125-8. PubMed ID: 14379186
    [No Abstract]   [Full Text] [Related]  

  • 10. Tests of compounds against Ehrlich ascites tumor, sarcoma 180 and Walker carcino-sarcoma 256.
    OETTEL H; WILHELM G
    Cancer Res; 1955; Suppl. 2():129-44. PubMed ID: 14379187
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytological analysis of effects of maleuric acid on Ehrlich ascites tumor cells.
    OKADA TA; ROBERTS E
    Cancer Res; 1960 Sep; 20():1154-9. PubMed ID: 13730569
    [No Abstract]   [Full Text] [Related]  

  • 12. [Relative biological activity of 250 kV, 31 MeV x-rays and electrons on solid Ehrlich ascites tumor].
    KAMMER HR
    Strahlentherapie; 1960 Oct; 113():178-92. PubMed ID: 13751071
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticancer activity of an essential oil from Cymbopogon flexuosus.
    Sharma PR; Mondhe DM; Muthiah S; Pal HC; Shahi AK; Saxena AK; Qazi GN
    Chem Biol Interact; 2009 May; 179(2-3):160-8. PubMed ID: 19121295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza virus infection of transplanted tumors. III. Effect of passive immunization on infections of the Ehrlich ascites tumor.
    WAGNER RR
    J Immunol; 1955 Jun; 74(6):446-54. PubMed ID: 14392330
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae).
    Da Silva SL; Chaar Jda S; Yano T
    Eur J Pharmacol; 2009 Apr; 608(1-3):76-83. PubMed ID: 19222998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chiral cyclopalladated complexes derived from N,N-dimethyl-1-phenethylamine with bridging bis(diphenylphosphine)ferrocene ligand as inhibitors of the cathepsin B activity and as antitumoral agents.
    Bincoletto C; Tersariol IL; Oliveira CR; Dreher S; Fausto DM; Soufen MA; Nascimento FD; Caires AC
    Bioorg Med Chem; 2005 Apr; 13(8):3047-55. PubMed ID: 15781414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the hereditary obese-hyperglycemic syndrome and of alloxan diabetes on the survival of mice with Ehrlich ascites carcinoma.
    JEHL J; MAYER J; McKEE RW
    Cancer Res; 1955 Jun; 15(5):341-3. PubMed ID: 14379176
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo growth inhibitory and anti-angiogenic effects of synthetic novel dienone cyclopropoxy curcumin analogs on mouse Ehrlich ascites tumor.
    Chandru H; Sharada AC; Bettadaiah BK; Kumar CS; Rangappa KS; Sunila ; Jayashree K
    Bioorg Med Chem; 2007 Dec; 15(24):7696-703. PubMed ID: 17869527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of technetium-labeled D-glucose-MAG3 derivative as agent for tumor diagnosis.
    de Barros AL; Cardoso VN; Mota Ld; Leite EA; Oliveira MC; Alves RJ
    Bioorg Med Chem Lett; 2009 May; 19(9):2497-9. PubMed ID: 19332368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer.
    Yanagihara K; Takigahira M; Tanaka H; Komatsu T; Fukumoto H; Koizumi F; Nishio K; Ochiya T; Ino Y; Hirohashi S
    Cancer Sci; 2005 Jun; 96(6):323-32. PubMed ID: 15958054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.